Press Release Molecular Targeting Technologies Presents First Clinical Validation of the Evans Blue Platform, Demonstrating Up to 15-Day Tumor Retention Using Approximately 12.5% of the Radioactivity Required for Conventional PRRT Jul 7
Press Release Emmecell Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for EO2002 for the Treatment of Corneal Endothelial Disease Jul 7
Press Release Capital City Fruit Becomes First Produce Distributor to Implement Farm-to-Retail Traceability Jul 7
Press Release Accel Entertainment, Inc. to Report Second Quarter 2026 Results, Host Conference Call and Webcast on August 4 Jul 7
Press Release Nexstar Media Group to Report 2026 Second Quarter Financial Results, Host Conference Call and Webcast on August 6 Jul 7
Press Release Zoetis Receives European Commission Marketing Authorization for Poulvac® Procerta® HVT-ND Jul 7